Tokyo Tape
Sign in
← Taiko Pharmaceutical

Half-year report · HY

4574.TEDINET S100YVYD
Period2026-01-01 → 2026-06-30
Filed2026-08-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.6bn2026-01-01 → 2026-06-30Cons.Net sales
Revenue¥6.4bn2025-01-01 → 2025-12-31Cons.Net sales (5-year summary)
Revenue¥2.4bn2025-01-01 → 2025-06-30Cons.Net sales
Operating income¥17m2026-01-01 → 2026-06-30Cons.Operating income
Operating income¥46m2025-01-01 → 2025-06-30Cons.Operating income
Ordinary income¥41m2026-01-01 → 2026-06-30Cons.Ordinary income
Ordinary income¥482m2025-01-01 → 2025-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥20m2025-01-01 → 2025-06-30Cons.Ordinary income
Profit before tax¥40m2026-01-01 → 2026-06-30Cons.Income before income taxes
Profit before tax¥382m2025-01-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)¥44m2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥923m2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥279m2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income¥44m2026-01-01 → 2026-06-30Cons.Profit loss
Net income¥279m2025-01-01 → 2025-06-30Cons.Profit loss
Total assets¥11.1bnat 2026-06-30Cons.Assets
Total assets¥12.3bnat 2025-12-31Cons.Assets
Total assets¥11.7bnat 2025-06-30Cons.Total assets (5-year summary)
Total liabilities¥2.7bnat 2026-06-30Cons.Liabilities
Total liabilities¥3.8bnat 2025-12-31Cons.Liabilities
Net assets / equity¥8.4bnat 2026-06-30Cons.Net assets
Net assets / equity¥8.5bnat 2025-12-31Cons.Net assets
Net assets / equity¥7.9bnat 2025-06-30Cons.Net assets (5-year summary)
Cash and deposits¥2.7bnat 2026-06-30Cons.Cash and deposits
Cash and deposits¥4.3bnat 2025-12-31Cons.Cash and deposits
Cash & equivalents¥2.7bnat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.1bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.5bnat 2024-12-31vCons.Cash and cash equivalents
Operating cash flow−¥66m2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥814m2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥61m2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥685m2026-01-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow¥142m2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥295m2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥853m2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.2bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥684m2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥0.892026-01-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥169.512025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.572025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio76.0%at 2026-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio69.4%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio68.1%at 2025-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Otherother segmentsrevenue2026-01-01 → 2026-06-30¥2m
Otherother segmentsrevenue external2026-01-01 → 2026-06-30¥2m
Otherother segmentssegment profit2026-01-01 → 2026-06-30−¥14m
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥433m
Infection Control Businessreportable segmentrevenue2026-01-01 → 2026-06-30¥111m
Infection Control Businessreportable segmentrevenue external2026-01-01 → 2026-06-30¥111m
Infection Control Businessreportable segmentsegment profit2026-01-01 → 2026-06-30−¥92m
Pharmaceuticals Businessreportable segmentrevenue2026-01-01 → 2026-06-30¥2.5bn
Pharmaceuticals Businessreportable segmentrevenue external2026-01-01 → 2026-06-30¥2.5bn
Pharmaceuticals Businessreportable segmentsegment profit2026-01-01 → 2026-06-30¥557m
Total Of Reportable Segments And Otherssegment totalrevenue2026-01-01 → 2026-06-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2026-01-01 → 2026-06-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2026-01-01 → 2026-06-30¥450m
Otherother segmentsrevenue2025-01-01 → 2025-06-30¥2m
Otherother segmentsrevenue external2025-01-01 → 2025-06-30¥2m
Otherother segmentssegment profit2025-01-01 → 2025-06-30−¥7m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥396m
Infection Control Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥203m
Infection Control Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥203m
Infection Control Businessreportable segmentsegment profit2025-01-01 → 2025-06-30−¥151m
Pharmaceuticals Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥2.2bn
Pharmaceuticals Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥2.2bn
Pharmaceuticals Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥601m
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-06-30¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-06-30¥2.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-06-30¥443m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 499
ItemContextValueUnit
Long term accounts payable otherPrior1YearInstant549000000JPY
Long term accounts payable otherInterimInstant549000000JPY
Provision for loss on subleases nclPrior1YearInstant4000000JPY
Provision for loss on subleases nclInterimInstant－JPY
Net defined benefit liabilityPrior1YearInstant623000000JPY
Net defined benefit liabilityInterimInstant638000000JPY
Asset retirement obligations nclPrior1YearInstant20000000JPY
Asset retirement obligations nclInterimInstant20000000JPY
Other nclPrior1YearInstant43000000JPY
Other nclInterimInstant53000000JPY
Noncurrent liabilitiesPrior1YearInstant1242000000JPY
Noncurrent liabilitiesInterimInstant1261000000JPY
LiabilitiesPrior1YearInstant3752000000JPY
LiabilitiesInterimInstant2666000000JPY
Capital stockPrior1YearInstant10000000JPY
Capital stockInterimInstant10000000JPY
Capital surplusPrior1YearInstant4978000000JPY
Capital surplusInterimInstant4960000000JPY
Retained earningsPrior1YearInstant3450000000JPY
Retained earningsInterimInstant3328000000JPY
Treasury stockPrior1YearInstant-237000000JPY
Treasury stockInterimInstant-202000000JPY
Shareholders equityPrior1YearInstant8200000000JPY
Shareholders equityInterimInstant8096000000JPY
Foreign currency translation adjustmentPrior1YearInstant317000000JPY
Foreign currency translation adjustmentInterimInstant329000000JPY
Valuation and translation adjustmentsPrior1YearInstant317000000JPY
Valuation and translation adjustmentsInterimInstant329000000JPY
Net assetsPrior1YearInstant8518000000JPY
Net assetsInterimInstant8425000000JPY
Liabilities and net assetsPrior1YearInstant12270000000JPY
Liabilities and net assetsInterimInstant11091000000JPY
Net salesPrior1InterimDuration2412000000JPY
Net salesInterimDuration2636000000JPY
Cost of salesPrior1InterimDuration1091000000JPY
Cost of salesInterimDuration1297000000JPY
Gross profitPrior1InterimDuration1320000000JPY
Gross profitInterimDuration1339000000JPY
Selling general and administrative expensesPrior1InterimDuration1273000000JPY
Selling general and administrative expensesInterimDuration1321000000JPY
Operating incomePrior1InterimDuration46000000JPY
Operating incomeInterimDuration17000000JPY
Interest income noiPrior1InterimDuration7000000JPY
Interest income noiInterimDuration12000000JPY
Foreign exchange gains noiPrior1InterimDuration－JPY
Foreign exchange gains noiInterimDuration10000000JPY
Other noiPrior1InterimDuration5000000JPY
Other noiInterimDuration3000000JPY
Non operating incomePrior1InterimDuration12000000JPY
Non operating incomeInterimDuration27000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-12-31pass
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass